|
Volumn 89, Issue 8, 2002, Pages 976-979
|
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
EPTIFIBATIDE;
ESTROGEN;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
PLACEBO;
TICLOPIDINE;
TIROFIBAN;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ANGIOPLASTY;
ARTERY DIAMETER;
ARTICLE;
ATHEROSCLEROSIS;
BLOOD CLOT LYSIS;
BOLUS INJECTION;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
CORONARY STENT;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG POTENCY;
FEMALE;
HEART CATHETERIZATION;
HEART DEATH;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERTENSION;
LEFT ANTERIOR DESCENDING CORONARY ARTERY;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
MALE;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE THROMBOSIS;
PRIORITY JOURNAL;
Q WAVE;
RISK ASSESSMENT;
RISK FACTOR;
SAPHENOUS VEIN GRAFT;
SEX DIFFERENCE;
THROMBOCYTE AGGREGATION;
THROMBOGENESIS;
TREATMENT OUTCOME;
AGED;
ANTIBODIES, MONOCLONAL;
CORONARY DISEASE;
FEMALE;
HEART CATHETERIZATION;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MIDDLE AGED;
PEPTIDES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
SEX FACTORS;
STENTS;
TREATMENT OUTCOME;
TYROSINE;
|
EID: 0037090375
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(02)02251-8 Document Type: Article |
Times cited : (22)
|
References (20)
|